5 Buy-Rated Stocks with Latest Insider Purchases
Robert James Wills, a director at Oncternal Therapeutics Inc (NASDAQ:ONCT), bought 3,086 shares of Oncternal Therapeutics Inc (NASDAQ:ONCT) at $8.96 per share.
April 14th, 2024 - Hedge Funds News
November 26th, 2020 - Hedge Funds News
May 28th, 2020 - Hedge Funds News
December 20th, 2019 - Hedge Funds News
Returns since its inception in May 2014 (through November 14th, 2024)